优化[18F]-FDOPA脑PET采集时间以评估临床环境中的帕金森综合征
本研究纳入20例患者,评估[18F]-FDOPA脑PET/CT在注射后90分钟采集时,不同采集时间(20、15、10、5分钟)对图像质量和FDOPA阳性判读的影响,以专家神经放射学临床判读为标准。结果显示采集时间≥10分钟时判读一致性高,15分钟时图像质量稳定,5分钟时图像质量低且判读不一致。
要点
- 采集时间≥10分钟时,两名阅片者间及与专家判读的FDOPA阳性一致性高。
- 15分钟采集时图像质量评分稳定,最大置信度一致性ρ=0.92、阅片者间κ=0.90。
- 5分钟采集时图像质量持续评为低且FDOPA阳性判读不一致。
核心结论
- 本研究提示图像质量评分在15分钟后稳定,采集至少10分钟至20分钟时两名阅片者间异常检出率高度一致,而5分钟时不一致。缩短[18F]-FDOPA PET采集时间可能有助于最大化患者舒适度并提高临床工作流程效率。
研究设计与样本
- 研究纳入20例患者,平均年龄65.6岁,55%为女性;注射185兆贝可勒尔(5毫居里)[18F]-FDOPA后90分钟行脑PET/CT,以列表模式采集20分钟并回放重建为15、10、5分钟采集数据;通过MIMneuro软件由2名阅片者在不知临床报告和诊断的情况下独立评分FDOPA阳性和图像质量,以专家神经放射学临床判读为标准。
诊断标准与关键数值
- 图像质量评分随采集时间缩短而下降(阅片者1 ρ=0.23,P=0.044;阅片者2 ρ=0.24,P=0.036);异常置信度评分与采集时间无关联(阅片者1 ρ=-0.13,P=0.250;阅片者2 ρ=-0.19,P=0.100);采集时间≥10分钟时组内和组间一致性及与专家判读一致性高,15分钟时最大置信度一致性ρ=0.92、阅片者间一致性κ=0.90;5分钟采集时图像质量持续评为低且FDOPA阳性判读不一致。
临床应用与阅片要点
- 作者认为缩短[18F]-FDOPA PET采集时间可能有助于最大化患者舒适度并提高临床工作流程效率;本研究提示采集至少10分钟至20分钟时判读一致性高,5分钟时不一致。
局限性
- 样本量小(20例患者)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Fluorine 18-fluoro-L-dopa ([18F]-FDOPA) was approved by the FDA in 2019 and reimbursed by the Centers for Medicare & Medicaid Services in 2022 for use with PET to visualize dopaminergic nerve terminals in the striatum for evaluation of parkinsonism. We sought to determine the optimal image acquisition time for [18F]-FDOPA PET by evaluating rater-estimated FDOPA positivity and image quality across 4 time points.
MATERIALS AND METHODS: Brain PET/CT was acquired 90 minutes following injection of 185 megabecquerel (5 mCi) of [18F]-FDOPA. PET was acquired in list mode for 20 minutes, and data were replayed to represent 15-, 10-, and 5-minute acquisitions. By means of MIMneuro, PET/MR imaging or PET/CT was independently graded for FDOPA positivity and image quality by 2 readers, blinded to the clinical report and diagnosis. Expert neuroradiologist clinical reads were used as the criterion standard.
RESULTS: Twenty patients were included, average age 65.6 years, 55% women. Image-quality ratings decreased with shorter acquisition times for both readers (reader 1, ρ = 0.23, P = .044; reader 2, ρ = 0.24, P = .036), but there was no association between abnormality confidence scores and acquisition time (reader 1, ρ = -0.13, P = .250; reader 2, ρ = -0.19, P = .100). There was a high degree of consistency in intra- and interrater agreement and agreement with the expert reads when using acquisition times of ≥10 minutes (maximal confidence score consistency [ρ = 0.92] and interrater agreement [κ = 0.90] were observed at 15 minutes), while image quality was consistently rated as low and FDOPA positivity ratings were inconsistent when using a 5-minute acquisition time.
CONCLUSIONS: Our study suggests that image-quality ratings were stable after 15 minutes and that between-subject abnormality detection rates were highly consistent between the 2 readers when acquired for at least 10 and up to 20 minutes but were inconsistent at 5 minutes. Shorter [18F]-FDOPA PET acquisition times may help maximize patient comfort while increasing throughput in the clinical setting.
引用
- Keir G, Mashriqi F, Caravella C, et al. Optimization of [18F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting. AJNR Am J Neuroradiol. 2024. PMID: 38663986. doi:10.3174/ajnr.A8207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。